欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
PT/H/1756/001
药品名称
Solifenacina Aristo
活性成分
Solifenacin succinate 5.0 mg
剂型
Film-coated tablet
上市许可持有人
Aristo Pharma Iberia, SL
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Germany (DE)
Netherlands (NL)
Solifenacin Aristo 5 mg, filmomhulde tabletten
United Kingdom (Northern Ireland) (XI)
Austria (AT)
Solifenacin Aristo 5 mg Filmtabletten
Spain (ES)
Italy (IT)
Poland (PL)
Slovakia (SK)
Czechia (CZ)
Aristissa
许可日期
2018/04/11
最近更新日期
2024/10/31
药物ATC编码
G04BD08 solifenacin
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Product Information
|
common_labip_solifenacin_10mg_fct_V01_0120
Date of last change:2024/09/06
Final Product Information
|
common_labip_solifenacin_5mg_fct_V01_0120
Date of last change:2024/09/06
Final Product Information
|
common_labop_solifenacin_10mg_fct_V01_0120
Date of last change:2024/09/06
Final Product Information
|
common_labop_solifenacin_5mg_fct_V01_0120
Date of last change:2024/09/06
Final Product Information
|
common_pl_solifenacin_5_10mg_fct_V01_0120
Date of last change:2024/09/06
Final Product Information
|
common_spc_solifenacin_5_10mg_fct_V01_0120
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase